Article
SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.
Antiviral research - 1 Mar 2015
Blanchet Matthieu, Sureau Camille, Guévin Carl, Seidah Nabil G, Labonté Patrick
Abstract excerpt
Worldwide, approximately 170 million individuals are afflicted with chronic hepatitis C virus (HCV) infection. To prevent the development of inherent diseases such as cirrhosis and hepatocellular carcinoma, tremendous efforts have been made, leading to the development of promising new treatments....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
